Mingbin Bao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mingbin Bao has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Junting Hu
Department of Neurosurgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
1 shared publication - Sen Lu
Department of Critical Care Medicine, Sichuan Provincial People’s Hospital, Affiliated Hospital of University of Electronic Science and Technology of China
1 shared publication
Latest Publications
- 20 January 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (1) , 53
EVADR lncRNA Mitigates Neonatal Hypoxic–Ischemic Brain Injury via the miR-145→WNT/β-Catenin Axis and Exhibits Biomarker Potential
Perinatal hypoxic–ischemic injury (HI) upregulated an endogenous retrovirus–derived lncRNA, EVADR, via HIF-1α/NF-κB. EVADR bound and repressed miR-145, thereby activating WNT/β-catenin signaling. Binding specificity was confirmed by biotin–miRNA pull-down and mutant-seed luciferase reporters. Genetic (si-CTNNB1/si-WNT3A) and pharmacologic (XAV939/CHIR99021) cross-validation demonstrated pathway necessity and rescue. EVADR gain-of-function reduced neuronal death and inflammation and improved behavioral outcomes following HI. Circulating EVADR levels in plasma/CSF correlated with injury severity; ROC analyses indicated diagnostic potential alone and combined with S100B/NSE. These data support EVADR–miR-145→WNT/β-catenin as a mechanistic axis with translational relevance. Graphical Abstract
- 20 January 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (1) , 53
EVADR lncRNA Mitigates Neonatal Hypoxic–Ischemic Brain Injury via the miR-145→WNT/β-Catenin Axis and Exhibits Biomarker Potential
Perinatal hypoxic–ischemic injury (HI) upregulated an endogenous retrovirus–derived lncRNA, EVADR, via HIF-1α/NF-κB. EVADR bound and repressed miR-145, thereby activating WNT/β-catenin signaling. Binding specificity was confirmed by biotin–miRNA pull-down and mutant-seed luciferase reporters. Genetic (si-CTNNB1/si-WNT3A) and pharmacologic (XAV939/CHIR99021) cross-validation demonstrated pathway necessity and rescue. EVADR gain-of-function reduced neuronal death and inflammation and improved behavioral outcomes following HI. Circulating EVADR levels in plasma/CSF correlated with injury severity; ROC analyses indicated diagnostic potential alone and combined with S100B/NSE. These data support EVADR–miR-145→WNT/β-catenin as a mechanistic axis with translational relevance. Graphical Abstract